CSLLY News and Press, CSL Ltd ADR From 02/22/22

CSL Plasma Makes $125,000 Donation to American Red Cross for Disaster Relief in U.S. Communities Donation supports local relief and recovery in communities impacted by 60,000+ natural disasters and emergencies that happen each year PR Newswire BOCA RATON, Fla. , ...

CSL Limited (CSLLY) Q2 2022 Earnings Conference Call February 15, 2022, 19:00 ET Company Participants Paul Perreault - MD, CEO & Executive Director Joy Linton - CFO Mark Dehring - Head, IR Conference Call Participants Lyanne Harrison - Bank of America Merrill Lynch David Low - JPMorgan Ch...

CSL Limited press release (OTCPK:CSLLY): 1H GAAP EPS of $3.85. Revenue of $6.04B (+5.2% Y/Y). For further details see: CSL Limited GAAP EPS of $3.85, revenue of $6.04B

Adma Biologics (NASDAQ:ADMA) activist holder Caligan Partners is said to be supportive of the company's ongoing strategic review. Adma rose 1.5.%. The activist would support a sale of the company for at least $3/share, according to a Dealreporter item, which cited sources familiar. Poten...

Seqirus, a Business of CSL Limited, Announces New Facility Supporting Research & Development of Leading-Edge Influenza Vaccine Technology Seqirus, a Business of CSL Limited, Announces New Facility Supporting Research & Development of Leading-Edge Influenza Vaccine Techno...

Final Analysis of Pivotal HOPE-B Study Demonstrates Durable and Sustained Therapeutic Effect of Etranacogene Dezaparvovec Gene Therapy in Hemophilia B - Data Presented at EAHAD 2022 - Data from the largest gene therapy study in Hemophilia B to date shows that etranacogene dezapa...

CSL BEHRING AG PUBLISHES OFFER PROSPECTUS ON PUBLIC TENDER OFFER FOR ALL PUBLICLY HELD SHARES OF VIFOR PHARMA LTD. Ad hoc release pursuant to Art. 53 LR, Switzerland PR Newswire MELBOURNE, Australia and ST. GALLEN, Switzerland , Jan. 18, 2022 /PRNewswire/...

After 5 good years, Project $1M had a very tough year in 2021 and had significant underperformance vs. the index. Despite this year's underperformance, the portfolio is still meaningfully up since 2015, the start of the portfolio. Emerging market growth suffered meaningfully, with...

CSL Behring Receives Accelerated CHMP Assessment for Etranacogene Dezaparvovec for European Patients Living with Hemophilia B PR Newswire KING OF PRUSSIA, Pa. , Dec. 15, 2021 /PRNewswire/ -- Global biotherapeutics leader CSL Behring today announced that ...

CSL (OTCPK:CSLLY -4.2%) to launch an all-cash public tender offer to acquire all publicly held Vifor Pharma shares for US$179.25 per Vifor Pharma share, for an aggregate equity value for Vifor Pharma of US$11.7 / A$16.4B. Patinex AG, Vifor Pharma's largest shareholder holding 23% of Vifo...